>> mccubbin: absolutely not. >> pelley: so how did cidra go wrong?rated to the same standard, to the same quality system that we had in place. the difference between cidra and all the rest of the plants is the effectiveness with which that quality system was implemented. it was much weaker, and that resulted in the compliance issues that occurred. >> pelley: cheryl eckard says that she was issuing warnings and no one was listening. >> mccubbin: i don't know cheryl eckard, and i don't all the details of her accusations. what i do know is that we were working with the f.d.a. before cheryl went to that plant. >> pelley: it was an f.d.a. inspection that first revealed problems at cidra, and that's why glaxo sent eckard's team in, to resolve those f.d.a. concerns. but eckard says she found much more than the f.d.a. did. f.d.a. inspections of drug plants are only occasional, so it's up to drug companies to police themselves. >> dr. jerry avorn: probably, most drugs are safe that people are taking, but there are scary examples like this that certainly raise